These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Investors are waiting for the release of the Federal Reserve's preferred inflation gauge as they eye Trump’s latest trade ...

Interest rates have fallen to their lowest level of the year as more investors believe Trump's tariff plans will hurt the US economy.

New research suggests their wandering focus for kids isn't a deficit—it might be a different, equally powerful way of ...

A fundamental principle of allocating your attention wisely is to alternate between coach and player modes. AI tools can facilitate self-coaching conversations. Ask your favorite chatbot to ask you 15 ...

TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia. TNX-102 SL demonstrated statistically significant ...

LEVEL-2, a global study, is expected to commence in 2025. “We are increasing our investment in the clinical development plan for TNX-103 by expanding the ongoing LEVEL study and accelerating our ...

(RTTNews) - Tenax Therapeutics, Inc. (TENX) announced an expansion of its Phase 3 LEVEL program for TNX-103 or oral levosimendan, a novel treatment for pulmonary hypertension with heart failure ...